<SEC-DOCUMENT>0001104659-19-014287-index.html : 20190312 <SEC-HEADER>0001104659-19-014287.hdr.sgml : 20190312 <ACCEPTANCE-DATETIME>20190312205937 ACCESSION NUMBER: 0001104659-19-014287 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20190312 DATE AS OF CHANGE: 20190312 EFFECTIVENESS DATE: 20190312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-230216 FILM NUMBER: 19676670 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>a19-6135_1s8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: a19-6135_1s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>a19-6135_1ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: a19-6135_1ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>a19-6135_1ex23d2.htm <DESCRIPTION>EX-23.2 <TEXT> Document 3 - file: a19-6135_1ex23d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.3 <SEQUENCE>4 <FILENAME>a19-6135_1ex23d3.htm <DESCRIPTION>EX-23.3 <TEXT> Document 4 - file: a19-6135_1ex23d3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>5 <FILENAME>a19-6135_1ex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 5 - file: a19-6135_1ex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g61351kii001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g61351kii001.jpg
</DOCUMENT> </SEC-DOCUMENT>